Letter to the Editor Regarding “The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence”

por Finck, Barbara, Geller, Robert B., Walden, Paul
Publicado 2021

Pharmacokinetic and Pharmacodynamic Bioequivalence of Pegfilgrastim-cbqv Delivered via a Prefilled Autoinjector and Prefilled Syringe in Healthy Male Participants

por Tang, Hong, Civoli, Francesca, Tatarewicz, Suzanna, Vandenkoornhuyse, Nathalie, Finck, Barbara
Publicado 2023

Biosimilar Pegfilgrastim-cbqv Demonstrated Similar Immunogenicity to Pegfilgrastim in Healthy Subjects Across Three Randomized Clinical Studies

por Civoli, Francesca, Finck, Barbara, Tang, Helen, Hodge, Jennifer, O’Kelly, Hillary, Vexler, Vladimir
Publicado 2022